research use only

Encenicline (EVP-6124) hydrochloride AChR agonist

Cat.No.S2957

Encenicline (EVP-6124) hydrochloride is a selective α7 nicotinic acetylcholine receptor partial agonist, improves memory performance by potentiating the acetylcholine response of α7 nicotinic acetylcholine receptors.
Encenicline (EVP-6124) hydrochloride AChR agonist Chemical Structure

Chemical Structure

Molecular Weight: 357.3

Jump to

Quality Control

Batch: S295701 DMSO]71 mg/mL]false]Ethanol]35 mg/mL]false]Water]Insoluble]false Purity: 99.34%
  • Cited in Nature Medicine for its top-tier quality
  • COA
  • NMR
  • HPLC
  • SDS
  • Datasheet
99.34

Solubility

In vitro
Batch:

DMSO : 71 mg/mL (198.71 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO.)

Ethanol : 35 mg/mL

Water : Insoluble

Molarity Calculator

Mass Concentration Volume Molecular Weight
Dilution Calculator Molecular Weight Calculator

In vivo
Batch:

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg
g
μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO
%
% Tween 80
% ddH2O
% DMSO
+
%

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Chemical Information, Storage & Stability

Molecular Weight 357.3 Formula

C16H17ClN2OS.ClH

Storage (From the date of receipt) 3 years -20°C powder
CAS No. 550999-74-1 -- Storage of Stock Solutions

Synonyms N/A Smiles Cl.ClC1=C2SC(=CC2=CC=C1)C(=O)NC3CN4CCC3CC4

Mechanism of Action

Targets/IC50/Ki
α7 nAChR
References

Clinical Trial Information

(data from https://clinicaltrials.gov, updated on 2024-05-22)

NCT Number Recruitment Conditions Sponsor/Collaborators Start Date Phases
NCT02246075 Withdrawn
Alzheimer''s Disease|Dementia|Cognition
FORUM Pharmaceuticals Inc|Quintiles Inc.
July 2015 Phase 2
NCT02327182 Terminated
Alzheimer''s Disease
Mitsubishi Tanabe Pharma Corporation
December 2014 Phase 3
NCT02004392 Terminated
Alzheimer''s Disease|Dementia
FORUM Pharmaceuticals Inc
June 2014 Phase 3
NCT01969123 Terminated
Alzheimer''s Disease|Dementia
FORUM Pharmaceuticals Inc
October 2013 Phase 3
NCT01969136 Terminated
Alzheimer''s Disease|Dementia
FORUM Pharmaceuticals Inc
October 2013 Phase 3
NCT01984736 Completed
Hepatic Impairment
FORUM Pharmaceuticals Inc|PRA Health Sciences
June 2013 Phase 1

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

Signaling Pathway Map